| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/06/2001 | DE10027024A1 Carbaminsäureester Carbamic |
| 12/06/2001 | DE10025464A1 Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen Combined use of enzyme inhibitors for the therapy of autoimmune diseases, transplantation and tumor diseases as well as combinations of enzyme inhibitors pharmaceutical preparations comprising |
| 12/06/2001 | CA2736344A1 Tnf-.alpha. production inhibitors |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2411666A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410889A1 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 12/06/2001 | CA2410735A1 Use of adnf for enhancing learning and memory |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 12/06/2001 | CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx |
| 12/06/2001 | CA2410630A1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | CA2410516A1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410475A1 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | CA2409964A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | CA2409932A1 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | CA2409617A1 2,7-naphthyridine derivatives |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | CA2408103A1 Tumor activated prodrug compounds and methods of making and using the same |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1160247A1 6,5-Fused aromatic ring systems having enhanced phosphodiesterae IV inhibitory activity |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1159961A2 Treatment of tumors with compounds having RxR retinoid receptor agonist activity |
| 12/05/2001 | EP1159445A1 Method to search for male antifertility drugs based on phgpx activity determination |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |
| 12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
| 12/05/2001 | EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s |
| 12/05/2001 | EP1159269A1 Anti-imflammatory indole derivatives |
| 12/05/2001 | EP1159264A2 INHIBITORS OF FACTOR Xa |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1158986A1 Protease inhibitors |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158982A2 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158970A1 Combinations of formoterol and a tiotropium salt |
| 12/05/2001 | EP1146050A9 Remedies |
| 12/05/2001 | EP1084270A4 Inhibition of coagulation in blood and blood products |
| 12/05/2001 | EP1017377B1 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions |
| 12/05/2001 | EP0970195A4 Fatty-acid amide hydrolase |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0851856B1 Indole derivatives as melatoninergic analogues |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0814754B1 Reduction of hair growth |
| 12/05/2001 | EP0789687B1 Ep2-receptor agonists as agents for lowering intraocular pressure |
| 12/05/2001 | EP0754176B1 Novel carbamates and ureas as modifiers of multi-drug resistance |
| 12/05/2001 | EP0710112B1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 12/05/2001 | EP0692972B1 Method for delivering beneficial compositions to hair follicles |
| 12/05/2001 | CN1325452A Method for the preparation of quercetin and isoquercetin derivatives |
| 12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
| 12/05/2001 | CN1325406A Crystalline forms of EtO2C-ch2-(r) Cgl-Aze-Pab-oh |
| 12/05/2001 | CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 12/05/2001 | CN1325398A Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 12/05/2001 | CN1325396A Aryl-{4-fluoro-4-[(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 12/05/2001 | CN1325393A Method for producing luteolin and luteolin derivatives |
| 12/05/2001 | CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325384A Anthranilic acid amides and the use thereof as medicaments |
| 12/05/2001 | CN1325376A Novel compounds and medicinal use thereof |
| 12/05/2001 | CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/05/2001 | CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 12/05/2001 | CN1324654A Cold eliminating pellet |
| 12/05/2001 | CN1324653A Health food capable of regulating blood lipoid and delaying senility |
| 12/05/2001 | CN1324643A Compound Yeqing tea and its prepn. |
| 12/05/2001 | CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor |
| 12/05/2001 | CN1075733C Face-nourishing oral liquor and its preparation method |
| 12/05/2001 | CN1075722C Fungicidal compositions containing bifonazole |
| 12/05/2001 | CN1075721C S-alkyl-DL-homocysteine-S,R-sulfinyl imine medicine |
| 12/04/2001 | US6326492 Heterocyclic protease inhibitors |
| 12/04/2001 | US6326490 Antiproliferation agents or anticarcinogenic agents |
| 12/04/2001 | US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents |
| 12/04/2001 | US6326403 Cardiovascular disorders |
| 12/04/2001 | US6326398 Oxamic acids and derivatives as thyroid receptor ligands |
| 12/04/2001 | US6326389 Administering sodium channel modulators |
| 12/04/2001 | US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| 12/04/2001 | US6326383 Emesis therapy |
| 12/04/2001 | US6326379 Fused pyridine inhibitors of cGMP phosphodiesterase |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 12/04/2001 | US6326377 Psychological disorders therapy |
| 12/04/2001 | US6326374 Analgesics; containing gamma aminobutyric acid |